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Abstract
Background: In 2007 an article was published describing the first forays into the practice of episcleral tattooing.
Currently only a handful of people worldwide have undergone this procedure, whereby a needle is used to inject
dye under the bulbar conjunctiva. To date there have been no previous reports of the risks and complications of
this emerging practice in the medical literature.
We present a case involving a complication that arose in one of the few people in Britain to have undergone
episcleral tattooing for cosmetic purposes.
Case presentation: A 43-year-old Caucasian man presented to the eye casualty clinic with red, lumpy conjunctivae
bilaterally, having undergone episcleral tattooing 7 weeks previously. On examination there were 3 distinct areas of
conjunctival swelling in each eye, representing a total of 6 injection sites. No other gross abnormalities were identified.
The clinical picture remained unchanged 6 months on, apart from a degree of fading of the conjunctival dye. He will
remain under our care to ensure that any further complications such as granulomatous inflammation are managed
and documented.
Conclusion: Episcleral tattooing is carried out by individuals with no medical training. The short-term complications
reported so far include: headaches, severe photophobia, persistent foreign body sensation, and migration of
ink staining. More serious short-term risks such as infection, globe penetration, and peri-ocular haemorrhage could
occur. For now we can only speculate as to the long-term consequences, but these may include carcinogenic change
or granulomatous inflammation. We feel that the potential risks of the procedure should be communicated more widely
to those body modification practitioners undertaking it. This practice could result in more serious presentations to acute
eye services in the future.
Background
In 2007 the Body Modification Ezine published an article
describing the first instances of episcleral tattooing [1].
At present only a handful of people worldwide have
undergone episcleral tattooing, whereby dye is injected
under the bulbar conjunctiva, for purely cosmetic pur-
poses. There have been no previous reports of the risks
and complications of this emerging practice in the med-
ical literature.
We present a case involving a complication in one
of the few people in Britain to have undergone episcl-
eral tattooing.
Case presentation
A 43-year-old man presented with bright red, lumpy con-
junctivae bilaterally (see Fig. 1). 7 weeks previously he had
undergone episcleral tattooing and his complaint was that
the conjunctival lumps had not subsided. In this case a
mixture of two dermal tattoo dyes (C.I Pigment Red 210
and C.I Pigment Blue 15) was injected under the conjunc-
tiva at 3 sites in each eye. Visual acuity was 6/4 in both
eyes and he reported no visual symptoms or discomfort.
On slit lamp examination there were 3 distinct areas
of conjunctival swelling in each eye, representing a total
of 6 injection sites (Fig. 2). Apart from this aesthetically
poor, persistent lumpy appearance, no other gross ab-
normalities were identified. Fundal examination and in-
traocular pressure measurements were also normal. The
clinical picture remained unchanged 6 months on, apart
from a degree of fading of the conjunctival dye (Fig. 3).
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He will remain under our care to ensure that any further
complications such as granulomatous inflammation are
managed and documented.
Conclusion
The number of body modification procedures carried
out annually is increasing [2] and new trends are push-
ing the boundaries of “extreme” in many directions. Pro-
cedures such as episcleral tattooing are carried out by
individuals with no medical training, who are taking it
upon themselves to pioneer an untested practice
through trial and error.
The short-term complications reported so far have in-
cluded: headaches, severe photophobia, persistent foreign
body sensation, and migration of ink staining to nearby tis-
sues [3, 4]. Episcleral tattooing by a non-ophthalmic trained
user without the use of a surgical microscope carries the
risk of globe penetration, traumatic cataract, retinal detach-
ment and endophthalmitis. In addition, tattoos carry the
risk of blindness from tattoo-induced uveitis [5–8]. If dis-
tant skin tattoos can induce uveal sensitization to the dyes
in the tattoo, placing the dye under the conjunctiva may re-
sult in more severe or more frequent uveitis. Finally, the
presence of chronic granuloma can lead in the long term to
scleral thinning or malignancy [9].
We feel that the potential risks of the procedure should
be communicated more widely to those body modification
practitioners undertaking it. This practice could result in
more serious presentations to acute eye services in the
coming years.
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Fig. 3 Left eye showing fading of conjunctival dye at 6 months
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